Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – Should You Buy?

Fresenius SE & Co. (OTCMKTS:FSNUY) shares gapped up prior to trading on Tuesday . The stock had previously closed at $12.10, but opened at $12.63. Fresenius SE & Co. shares last traded at $12.7068, with a volume of 1,645 shares trading hands.

Wall Street Analyst Weigh In

Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, June 23rd. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Fresenius SE & Co. presently has a consensus rating of “Buy”.

Fresenius SE & Co. Price Performance

The stock has a market capitalization of $28.20 billion, a P/E ratio of 16.69 and a beta of 0.63. The business’s 50 day simple moving average is $11.39 and its two-hundred day simple moving average is $13.07. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41.

Fresenius SE & Co. (OTCMKTS:FSNUY) last posted its earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). The business had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%. As a group, sell-side analysts forecast that Fresenius SE & Co. will post 1.03 earnings per share for the current fiscal year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.